Skip to main content

Table 2 Descriptive characteristics of older Medicare enrollees with rheumatoid arthritis, psoriatic arthritis, and osteoarthritis

From: The delivery of evidence-based preventive care for older Americans with arthritis

Variable

Rheumatoid arthritis

N = 141,140

Psoriatic arthritis

N = 6,300

Osteoarthritis

N = 770,520

Demographics

   

Age

   

   65 to 69

32.5

39.4

23.9

   70 to 74

31.2

31.8

27.1

   75 to 84

22.3

18.7

25.4

   85+

10.4

8.3

15.0

Gender, %

   

   Female

76.9

60.0

72.9

   Male

23.1

40.0

27.1

Race, %

   

   Asian

0.8

-

1.1

   Black

6.4

-

7.7

   Hispanic

1.6

-

2.0

   Other

1.2

-

1.0

   White

90.0

97.1

88.2

Rural/Urban, %

   

   Urban Core

64.3

71.4

65.1

   Not Urban Core

35.8

25.6

34.9

Geographic Region, %

   

   Northeast

20.5

26.7

20.9

   Midwest

26.1

21.9

24.6

   West

14.9

13.3

14.8

   South

38.5

38.1

39.6

Income in $, %

   

   0 to - <30,000

20.0

13.7

22.5

   30,000 to <45,000

39.4

34.0

38.3

   45,000 to <60,000

22.3

22.2

21.2

   60,000 to <75,000

10.5

14.6

9.7

   75,000+

7.8

15.6

8.3

Comorbidities, %

   

   Myocardial infarction

2.5

-

2.5

   Heart failure

5.6

3.5

6.4

   Cardiovascular disease

4.1

5.4

5.4

   Dementia

0.5

-

0.8

   Chronic pulmonary disease

14.1

11.8

13.4

   Cancer (any)

6.7

7.6

7.6

   Hypertension

37.1

42.2

49.0

   Osteopenia

0.8

-

0.9

   Osteoporosis

9.7

5.1

7.0

   Closed hip fracture

0.8

-

0.7

Physician Specialty (≥2 visits), %

   

   No rheumatology and no primary care

6.5

5.1

18.9

   Rheumatology but no primary care

23.9

27.0

4.2

   Primary care but no rheumatology

30.9

21.6

68.4

   Both Rheumatology and primary care

38.7

46.4

8.5

Physician Visits, n

14.3 (0, 142)

15.2 (2, 64)

12.8 (0, 168)

Number of days of inpatient hospitalization, n

2.2 (0, 365)

1.7 (0, 66)

3.0 (0, 348)

Receipt of any Long Term Care, %

2.3

0.6

3.5

  1. Data shown as % or as mean (range). All data were assessed in the 12-month baseline period before the start of the five-year observation period.
  2. Totals may not sum to exactly 100% due to rounding.
  3. Cells with a "-"were suppressed due to requirements imposed by data use agreement restrictions related to small cell sizes